CDMO Vibalogics, speeding toward U.S. commercial plant, pumps $50M into viral vector capacity

SourceFierce Pharma
Date Published06/10/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Vibalogics
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2021
Capital investment ($):150
Country(ies) from which reshored:Germany
City reshored to:Boxborough
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredoncolytic viruses and viral vectors
What domestic positive factors made reshoring more attractive?, covid-19
Find Reshoring Articles